IRIS
PISATURO, Mariantonietta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.180
NA - Nord America 6.549
AS - Asia 4.802
SA - Sud America 798
Continente sconosciuto - Info sul continente non disponibili 342
AF - Africa 79
OC - Oceania 4
Totale 23.754
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 7.565
US - Stati Uniti d'America 6.387
SG - Singapore 1.769
IE - Irlanda 1.293
CN - Cina 864
HK - Hong Kong 801
IT - Italia 734
BR - Brasile 659
VN - Vietnam 588
DE - Germania 423
GB - Regno Unito 331
UA - Ucraina 318
KR - Corea 217
JP - Giappone 161
IN - India 134
FI - Finlandia 106
SE - Svezia 89
TR - Turchia 84
CA - Canada 80
GR - Grecia 77
FR - Francia 68
AR - Argentina 58
BD - Bangladesh 38
AT - Austria 29
IQ - Iraq 29
PL - Polonia 27
ZA - Sudafrica 27
MX - Messico 24
NL - Olanda 23
CO - Colombia 22
PK - Pakistan 19
ES - Italia 17
ID - Indonesia 17
BE - Belgio 15
EC - Ecuador 15
VE - Venezuela 14
JM - Giamaica 10
MA - Marocco 10
CR - Costa Rica 9
CZ - Repubblica Ceca 9
HN - Honduras 9
IR - Iran 9
LT - Lituania 8
PE - Perù 8
RS - Serbia 8
AL - Albania 7
EG - Egitto 7
JO - Giordania 7
KE - Kenya 7
UY - Uruguay 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
CL - Cile 6
DZ - Algeria 6
EU - Europa 6
PA - Panama 6
TN - Tunisia 6
BB - Barbados 5
KZ - Kazakistan 5
PY - Paraguay 5
RO - Romania 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
IL - Israele 4
KG - Kirghizistan 4
PH - Filippine 4
PS - Palestinian Territory 4
SA - Arabia Saudita 4
SN - Senegal 4
TT - Trinidad e Tobago 4
CM - Camerun 3
DK - Danimarca 3
EE - Estonia 3
GE - Georgia 3
LB - Libano 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BY - Bielorussia 2
CD - Congo 2
GA - Gabon 2
LV - Lettonia 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 23.404
Salva come PNG Salva come JPEG
Città #
Moscow 2.748
Dublin 1.293
Santa Clara 810
Hong Kong 793
Singapore 716
San Jose 713
Ashburn 650
Jacksonville 479
Chandler 439
Council Bluffs 434
Seoul 215
Ho Chi Minh City 181
Bremen 178
Princeton 177
Hanoi 149
Roxbury 146
New York 129
Milan 125
Cambridge 119
Beijing 114
Dallas 114
Hefei 112
The Dalles 82
Los Angeles 74
Ann Arbor 73
Caserta 72
Bengaluru 68
Munich 68
São Paulo 64
Medford 58
Boardman 55
Naples 54
Memphis 49
Wilmington 47
Orem 46
Da Nang 45
Miano 44
Woodbridge 39
San Mateo 33
Washington 31
Des Moines 26
Haiphong 24
Warsaw 23
Nuremberg 22
Rome 22
Chennai 21
Frankfurt am Main 21
Biên Hòa 20
Tokyo 20
Atlanta 18
Denver 18
Helsinki 18
Nanjing 18
London 17
Montreal 17
Brasília 16
Mountain View 16
Rio de Janeiro 16
San Francisco 16
Brussels 15
Napoli 15
Toronto 15
Vienna 15
Chicago 14
Johannesburg 14
Jinan 13
Manchester 13
Tianjin 13
Amsterdam 12
Curitiba 12
Düsseldorf 12
Hillsboro 12
Houston 12
Istanbul 12
Phoenix 12
Brooklyn 11
Campinas 11
Hải Dương 11
Mumbai 11
Porto Alegre 11
Stockholm 11
Belo Horizonte 10
Changsha 10
Brno 9
Bến Tre 9
Florence 9
Guangzhou 9
Paris 9
Shanghai 9
Auburn Hills 8
Aversa 8
Boston 8
Grafing 8
Kingston 8
North Bergen 8
Philadelphia 8
Shenyang 8
Thái Bình 8
Zhengzhou 8
Bologna 7
Totale 12.643
Salva come PNG Salva come JPEG
Nome #
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 220
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 215
Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection 205
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 199
Liver microRNA hsa-miR-125a-5p in HBV Chronic Infection: Correlation with HBV Replication and Disease Progression 196
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 187
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 186
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 186
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 186
733 REACTIVATION OF OVERT AND OCCULT HBV INFECTION IN IMMUNOSUPPRESSIVE SETTINGS Journal of Hepatology 176
Abstracts of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases. November 9-13, 2012. Boston, Massachusetts, USA. 175
Absence of occult HCV infection in patients experiencing an immunodepression condition 175
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 172
Blood-borne chronic viral infections in a large cohort of immigrants in southern Italy: A seven-centre, prospective, screening study 170
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 168
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 166
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 164
Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment 161
416 molecular analysis of genetic variability and epitope stability in a type 1B recurrent HCV infection 160
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013 158
Clinical findings of HCV chronic infection in undocumented immigrants and low-income refugees in three areas of southern Italy 158
Absence of occult HCV infection in HIV-positive patients 157
540 IDENTIFICATION OF LAMIVUDINE RESISTANT HBV STRAIN RT204V/I IN ACUTE HEPATITIS B IN ITALY 157
579 CHANGING PATTERN OF HBV GENOTYPES IN ITALY 156
Clinical and virological characteristics associated with severe acute hepatitis B 150
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study 148
ACUTE EXACERBATION OF CHRONIC HEPATITIS C: CLINICAL PRESENTATION, OUTCOME AND RESPONSE TO ANTI-HCV TREATMENT 148
Acute hepatitis C: Clinical and laboratory diagnosis, course of the disease, treatment 146
Risk and prevention of hepatitis b virus reactivation during immunosuppression for non-oncological diseases 146
Bidirectional Relationship between HIV/HBV Infection and Comorbid Depression and/or Anxiety: A Systematic Review on Shared Biological Mechanisms 145
Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features 145
Characteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy 144
An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta-analysis 142
A HIGH HBSAG GENETIC COMPLEXITY CAN INFLUENCE HBV IMMUNOGENICITY IN THE SETTING OF ACUTE INFECTION 142
Directly acting antiviral-based treatment for hcv-infected persons who inject drugs: A multicenter real-life study 142
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection 139
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 138
Epidemiology and management of hepatitis C virus infections in immigrant populations 138
F-6 Efficacy and tolerability of peginterferon a-2a and a-2b in patients with chronic hepatitis C by genotype 1: A meta-analysis 137
Clinical Characterization of the Three Waves of COVID-19 Occurring in Southern Italy: Results of a Multicenter Cohort Study 136
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 136
A HIGH GENETIC HETEROGENEITY IN HBsAg CAN AFFECT IMMUNOGENICITY IN ACUTE HEPATITIS B INFECTION 136
The reactivation of occult HBV infection emerging with the case of acute hepatitis B in the wife of a subject treated with rituximab-based chemotherapy 135
Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: A meta-analysis 135
Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy 133
Different Clinical Outcomes of COVID-19 in Two Healthcare Workers Vaccinated with BNT162b2 Vaccine, Infected with the Same Viral Variant but with Different Predisposing Conditions for the Progression of the Disease 132
Absence of occult HCV infection in HIV-positive patients 132
Bloodstream Infection Due to a VIM-Metallo-β-Lactamase-Producing Klebsiella pneumoniae Treated with Cefiderocol in a Preterm Newborn 131
Effectiveness of test-and-treat model with direct-acting antiviral for hepatitis C virus infection in migrants: a prospective interventional study in Italy 131
Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: a meta-analysis on the role of response predictors 131
Clinical Presentation, Outcomes, and Response to Therapy Among Patients with Acute Exacerbation of Chronic Hepatitis C. 131
Absence of occult hepatitis C virus infection in patients under immunosupressive therapy for oncohematological diseases 131
Virological factors associated with failure to the latest generation of direct acting agents (Daa) and re-treatment strategy: A narrative review 131
Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study 130
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis 130
Efficacy and Tollerability of INI-Based 2-Drug Regimen in Virosuppressed Persons Living with HIV: A Systematic Review and Meta-Analysis 129
A STRATEGY TO FAVOR THE ACCESS OF IRREGULAR AND REFUGEE MIGRANTS TO A SCREENING PROGRAM FOR HBV, HCV AND HIV INFECTION 129
Pharmacotherapies for multidrug-resistant gram-positive infections: current options and beyond 128
A STRATEGY TO FAVOR THE ACCESS OF IRREGULAR AND REFUGEE MIGRANTS TO A SCREENING PROGRAM FOR HBV, HCV AND HIV INFECTION 128
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 128
Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data 127
Innovative procedures for micro-elimination of HCV infection in persons who use drugs 126
Characterization of hepatitis virus co-infections in a cohort of immigrants living in southern Italy 126
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study 125
Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic 125
Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area. 125
P.216 Molecular analysis of genetic variability and epitope stability in a type 1b recurrent HCV infection 125
Clinical and virological characteristics associated with severe acute hepatitis B 125
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial 124
Tm6sf2 e167k variant is associated with severe steatosis in chronic hepatitis c, regardless of pnapl3 polymorphism 124
Role of genetic polymorphisms in hepatitis C virus chronic infection 124
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B 124
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 124
The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy. 123
Liver biopsy in chronic hepatitis C: the experience of 15 Italian wards of infectious diseases. 123
T-14 Virological and clinical impact of anti-HBV nucleos(t)ide analogues in cirrhotic patients with HBV-HCV coinfection 123
Occult HBV infection in the oncohematological setting. 123
Management of HBV reactivation in non-oncological patients 123
COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature 122
An update on the treatment options for HBV/HCV coinfection 122
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 121
Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection 121
Early predictors of clinical deterioration in a cohort of outpatients with COVID-19 in southern Italy: A multicenter observational study 120
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study 120
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 120
HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient 119
CANNABINOID RECEPTOR 2 (CB2) 63 QQ VARIANT IS ASSOCIATED WITH A SEVERE HISTOLOGICAL ACTIVITY INDEX IN PATIENTS WITH CHRONIC HEPATITIS C 118
Clinical Presentation, Outcome, and Response to Therapy Among Patients With Acute Exacerbation of Chronic Hepatitis C 118
The association between education level and chronic liver disease of any etiology 117
Infezione da HBV in soggetti immigrati: risultati preliminari di uno studio prospettico multicentrico 116
Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report 115
Improvement in the aetiological diagnosis of acute hepatitis C: A diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index 115
Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings 115
Role of occult hepatitis B virus infection in chronic hepatitis C 114
Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index. 113
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact 113
Clinical features of patients with home isolation SARS-COV-2 infection: A multicenter retrospective study in southern Italy 112
Hbv/hdv co‐infection: Epidemiological and clinical changes, recent knowledge and future challenges 112
HDV infection in immigrant populations 112
Hepatitis C late relapse in patients with directly acting antiviral-related sustained virological response at week 12 112
Totale 13.972
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.621
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022861 0 0 0 8 210 13 104 11 23 83 66 343
2022/20232.137 193 56 27 115 299 127 2 102 1.126 15 37 38
2023/2024985 68 23 73 68 350 116 15 26 10 11 48 177
2024/20253.141 9 39 14 86 475 439 387 295 527 456 234 180
2025/202612.683 499 594 649 608 1.079 7.033 673 436 462 293 227 130
2026/20272.040 77 240 900 823 0 0 0 0 0 0 0 0
Totale 23.754